Focus problems in diagnosis and treatment of recurrent hepatocellular carcinom
10.19538/j.cjps.issn1005-2208.2019.10.06
- Author:
Zhen-guang WANG
1
;
Wei-ping ZHOU
1
Author Information
1. The 3rd Department of Hepatic Surgery,Eastern Hepato-biliary Surgical Hospital,Naval Medical University Shanghai 200438,China
- Publication Type:Journal Article
- Keywords:
recurrent hepatocellular carcinoma;
prognostic factor;
surgical resection;
liver transplantation;
laparoscopy
- From:
Chinese Journal of Practical Surgery
2019;39(10):1027-1030
- CountryChina
- Language:Chinese
-
Abstract:
Recurrent hepatocellular carcinoma(HCC) is acommon problem in the treatment of HCC patients. At present,there is a lack of staging and treatment system for recurrenthepatocellular carcinoma,and a lack of high-level clinicalresearch. Therefore,there is much controversy in the treatmentof recurrent hepatocellular carcinoma. The controversy ismainly focused on whether it is proper to take aggressivelyrepeated surgical resection or liver transplantation. For recurrent tumors of polyclonal origin,clinical treatmentdecisions are basically based on the staging and treatmentsystem of primary hepatocellular carcinoma,and the prognosisis not inferior to that of primary tumors. For recurrent tumorsof monoclonal origin,it tends to be less invasive,such asinterventional,ablation,radiotherapy or targeted drugs. Thetreatment strategy for hepatocellular carcinoma must considermany factors, such as trauma,safety,effectiveness and cost. Itis similar to and still a little different from that of primaryhepatocellular carcinoma. Therefore,the treatment of recurrenthepatocellular carcinoma cannot fully refer to the treatmentsystem of primary hepatocellular carcinoma.
